Discovery of potent and stable conformationally constrained analogues of the MCH R1 antagonist SB-568849
摘要:
A strategy of systematically targeting more rigid analogues of the known MCH R1 receptor antagonist, SB-568849, serendipitously uncovered a binding mode accessible to N-aryl-phthalimide ligands. Optimisation to improve the stability of this compound class led to the discovery of novel N-aryl-quinazolinones, benzotriazinones and thienopyrimidinones as selective ligands with good,affinity for human melanin-concentrating hormone receptor 1. (c) 2006 Elsevier Ltd. All rights reserved.
Discovery of potent and stable conformationally constrained analogues of the MCH R1 antagonist SB-568849
摘要:
A strategy of systematically targeting more rigid analogues of the known MCH R1 receptor antagonist, SB-568849, serendipitously uncovered a binding mode accessible to N-aryl-phthalimide ligands. Optimisation to improve the stability of this compound class led to the discovery of novel N-aryl-quinazolinones, benzotriazinones and thienopyrimidinones as selective ligands with good,affinity for human melanin-concentrating hormone receptor 1. (c) 2006 Elsevier Ltd. All rights reserved.
Lactam derivatives as antagonists for human 11cby receptors
申请人:Armstrong Anne Sula
公开号:US20050059651A1
公开(公告)日:2005-03-17
The invention provides compounds of formula (I)
a salt, or solvate thereof.
该发明提供了式(I)的化合物,其盐或溶剂。
Novel Lactam Derivatives
申请人:Armstrong Anne Sula
公开号:US20060287321A1
公开(公告)日:2006-12-21
The invention thus provides compounds of formula (I)
a salt, or solvate thereof.
该发明因此提供了公式(I)的化合物,其盐或溶剂。
LACTAM DERIVATIVES AS ANTAGONISTS FOR HUMAN 11CBY RECEPTORS
申请人:SMITHKLINE BEECHAM PLC
公开号:EP1436267B1
公开(公告)日:2006-12-27
US7220777B2
申请人:——
公开号:US7220777B2
公开(公告)日:2007-05-22
Discovery of potent and stable conformationally constrained analogues of the MCH R1 antagonist SB-568849
作者:David R. Witty、John Bateson、Guillaume J. Hervieu、Kamal Al-Barazanji、Phillip Jeffrey、Dieter Hamprecht、Andrea Haynes、Christopher N. Johnson、Alison I. Muir、Peter J. O’Hanlon、Geoffrey Stemp、Alex J. Stevens、Kevin Thewlis、Kim Y. Winborn
DOI:10.1016/j.bmcl.2006.06.061
日期:2006.9
A strategy of systematically targeting more rigid analogues of the known MCH R1 receptor antagonist, SB-568849, serendipitously uncovered a binding mode accessible to N-aryl-phthalimide ligands. Optimisation to improve the stability of this compound class led to the discovery of novel N-aryl-quinazolinones, benzotriazinones and thienopyrimidinones as selective ligands with good,affinity for human melanin-concentrating hormone receptor 1. (c) 2006 Elsevier Ltd. All rights reserved.